Consistent with our results showing ACSL3 to be the most essential ACSL family member for ccRCC lipid metabolism, targeting ACSL3 with siRNA lead to a reduction in cell viability compared with controls (Fig. 3C). Here, ACSL3 is linked to nonpapillary renal cell carcinoma.